BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2151774)

  • 1. Role of atrial natriuretic peptides and neuropeptide Y in blood pressure regulation.
    Waeber B; Burnier M; Nussberger J; Brunner HR
    Horm Res; 1990; 34(3-4):161-5. PubMed ID: 2151774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y and cardiovascular regulation.
    Pedrazzini T; Brunner HR; Waeber B
    Curr Opin Nephrol Hypertens; 1993 Jan; 2(1):106-13. PubMed ID: 7922157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
    Bauer WR; Neubauer S; Obitz G; Ertl G
    J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides buffer renin-dependent hypertension.
    Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide: a new factor in hormonal control of blood pressure and electrolyte homeostasis.
    Atlas SA; Laragh JH
    Annu Rev Med; 1986; 37():397-414. PubMed ID: 2939792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of vasoactive peptides in blood pressure control.
    Brunner HR
    J Hum Hypertens; 1993 Aug; 7(4):375-81. PubMed ID: 8410929
    [No Abstract]   [Full Text] [Related]  

  • 7. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.
    Laragh JH
    N Engl J Med; 1985 Nov; 313(21):1330-40. PubMed ID: 2932646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides.
    Dumont Y; Chabot JG; Quirion R
    Peptides; 2004 Mar; 25(3):365-91. PubMed ID: 15134861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of neuropeptide Y in renal sympathetic vasoconstriction: studies in normal and congestive heart failure rats.
    DiBona GF; Sawin LL
    J Lab Clin Med; 2001 Aug; 138(2):119-29. PubMed ID: 11477379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concentration of neuropeptide Y in serum of patients with primary hypertension].
    Halawa B; Salomon P
    Pol Arch Med Wewn; 1996 May; 95(5):420-6. PubMed ID: 8848409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions.
    Imura H; Nakao K; Itoh H
    Front Neuroendocrinol; 1992 Jul; 13(3):217-49. PubMed ID: 1334000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.
    Atlas SA; Volpe M; Sosa RE; Laragh JH; Camargo MJ; Maack T
    Fed Proc; 1986 Jun; 45(7):2115-21. PubMed ID: 2940120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel endogenous peptides acting on cardiovascular system].
    Goto K; Kimura S; Masaki T
    Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1925-39. PubMed ID: 2146704
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuropeptide Y and cardiovascular regulation.
    McCloskey DI; Potter EK
    Clin Exp Pharmacol Physiol; 1991 Jan; 18(1):47-9. PubMed ID: 2032391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colocalization of receptors for vasoactive peptides on astrocytes of cultured rat spinal cord and brain stem: electrophysiological effects of atrial and brain natriuretic peptide, neuropeptide Y and bradykinin.
    Hösli L; Hösli E; Kaeser H; Lefkovits M
    Neurosci Lett; 1992 Dec; 148(1-2):114-6. PubMed ID: 1338645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atrial natriuretic peptide. I: Biochemistry, general pharmacology and physiology. A review].
    Vollmar AM
    Tierarztl Prax; 1990 Jun; 18(3):219-23. PubMed ID: 2165639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
    Malmström RE; Lundberg JM
    Acta Physiol Scand; 1997 Nov; 161(3):327-38. PubMed ID: 9401585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
    Klemm SA; Tunny TJ; Gordon RD
    J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
    J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.